References
Edelbauer M, Jungraithmayr T, Zimmerhackl LB (2005) Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression. Pediatr Nephrol 20:811–813
Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, Tullus K (2005) B lymphocyte depletion in children with refractory systemic lupus erythematosus. Arthritis Rheum 52:3168–3174
Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA (2002) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 46:2673–2677
Weide R, Heymanns J, Pandorf A, Köppler H (2003) Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 12:779–782
Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA (2005) B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology 44:1542–1545
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marks, S.D., Tullus, K. Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus. Pediatr Nephrol 21, 598–599 (2006). https://doi.org/10.1007/s00467-006-0024-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0024-7